15 results found.

Breast Cancer, or Neoplasm Metastasis Clinical Trial using Standard supportive care (packed RBC transfusion); epoetin alfa + packed RBC transfusion

Janssen Research & Development, LLC - Recruiting 18 years or older.
- A Randomized, Open-label, Multicenter, Phase 3 Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.
Standard supportive care (packed RBC transfusion); epoetin alfa + packed RBC transfusion

Breast Cancer, Breast Neoplasm, Breast Tumor, or Cancer of the Br Clinical Trial using Proton Radiotherapy

Proton Collaborative Group - Recruiting 50 years or older.
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer.
Proton Radiotherapy

Breast Cancer, Breast Neoplasm, Breast Tumor, or Cancer of the Br Clinical Trial using Proton Radiotherapy

Proton Collaborative Group - Recruiting 18 years or older.
- Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Women With Stage III,Loco-Regional, Non-Metastatic Breast Cancer.
Proton Radiotherapy

Breast Neoplasm, or Metastasis Clinical Trial using Eribulina

Medica Scientia Innovation Research - Recruiting 18 years or older.
- A Phase IIa Prospective, Multicenter, Open and Not Controlled of the Efficacy and Tolerability on the First Line Treatment With Eribulin as a Unic Agent on Patients With HER2 Negative Metastatic Breast Cancer Previously Treated With Taxanes.
Eribulina

Breast Neoplasm Clinical Trial

Medica Scientia Innovation Research - Recruiting 18 years or older.
- Observational, Retrospective and Multicenter Study to Evaluate the Clinical Benefit of Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib.

Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, or Clinical Trial using cognitive intervention; questionnaire administration; quality-of-life assessment; blood-oxygen-level-dependent functional magnetic resonance imaging; memory intervention

University of Washington - Recruiting 21 years to 90 years.
- Behavioral and Neural Indices of Cognitive Rehabilitation in Women's Cancer: A Pilot Study..
cognitive intervention; questionnaire administration; quality-of-life assessment; blood-oxygen-level-dependent functional magnetic resonance imaging; memory intervention

Malignant Neoplasm of Breast, CNS Malignancy, Malignant Neoplasm Clinical Trial using Alisertib; Pazopanib

University of Illinois at Chicago - Recruiting 18 years or older.
- Phase I Study of Aurora A Kinase Inhibitor (MLN8237) Given in Combination With Selective VEGFR Inhibitor Pazopanib (Votrient) for Therapy in Solid Tumors.
Alisertib; Pazopanib

Physical Activity, Breast Neoplasm, Colorectal Neoplasm, or Gall Clinical Trial

Sahlgrenska University Hospital, Sweden - Recruiting 18 years or older.
- The Impact of Physical Activity on the Outcome of Surgery.

Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Clinical Trial using assessment of therapy complications

Southwest Oncology Group - Recruiting N/A or older.
- S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.
assessment of therapy complications

Breast Cancer, or Locally Advanced Malignant Neoplasm Clinical Trial using Cholecalciferol; Inj. Progesterone; Doxyrubicin or Epirubicin

Tata Memorial Hospital - Recruiting 18 years to 70 years.
- Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With LOBC and LABC - A Feasibility Study.
Cholecalciferol; Inj. Progesterone; Doxyrubicin or Epirubicin

Breast Neoplasm Clinical Trial using Tesetaxel once every 3 weeks; Tesetaxel once weekly

Genta Incorporated - Recruiting 18 years or older.
- A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer.
Tesetaxel once every 3 weeks; Tesetaxel once weekly

Breast Neoplasms, Endocrine Breast Diseases, or Neoplasm Metastas Clinical Trial using letrozole; lapatinib; everolimus

University of Maryland - Recruiting 18 years or older.
- GCC 0901- A Phase II Study of Letrozole in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast Cancer.
letrozole; lapatinib; everolimus

Breast Cancer, or Neoplasm Metastasis Clinical Trial using Non pegylated liposomal doxorubicin, trastuzumab, docetaxel

Catharina Ziekenhuis Eindhoven - Recruiting 18 years or older.
- Phase II Multicentre Open Label Study Evaluating the Efficacy and Safety of Liposomal Doxorubicin, Trastuzumab, Docetaxel as First-line Treatment of Patients With HER2 Positive Metastatic Breast Cancer.
Non pegylated liposomal doxorubicin, trastuzumab, docetaxel

Breast Neoplasms, or Neoplasm Metastasis Clinical Trial

Beijing Cancer Hospital - Recruiting 18 years to 75 years.
- Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy.

Breast Neoplasms, Neoplasm Metastasis, Gene Expression Profiling, Clinical Trial using cytokine

Beijing Cancer Hospital - Recruiting 18 years to 75 years.
- Gene Expression Profiling of Breast Cancer Cells in Pleural Effusion Prodict the Response of Malignant Pleural Effusion to Immunotherapy.
cytokine